Australia markets closed

Quest Diagnostics Incorporated (DGX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
136.51+0.17 (+0.12%)
As of 02:21PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 15.15B
Enterprise value 20.02B
Trailing P/E 18.35
Forward P/E 15.50
PEG ratio (5-yr expected) 1.60
Price/sales (ttm)1.66
Price/book (mrq)2.35
Enterprise value/revenue 2.16
Enterprise value/EBITDA 11.49

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3-0.12%
S&P500 52-week change 322.43%
52-week high 3145.58
52-week low 3119.59
50-day moving average 3129.97
200-day moving average 3131.15

Share statistics

Avg vol (3-month) 31.03M
Avg vol (10-day) 31.38M
Shares outstanding 5111.09M
Implied shares outstanding 6111.06M
Float 8110.07M
% held by insiders 10.43%
% held by institutions 191.53%
Shares short (15 Apr 2024) 43.02M
Short ratio (15 Apr 2024) 43.34
Short % of float (15 Apr 2024) 43.11%
Short % of shares outstanding (15 Apr 2024) 42.72%
Shares short (prior month 15 Mar 2024) 42.65M

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 42.20%
Trailing annual dividend rate 32.88
Trailing annual dividend yield 32.11%
5-year average dividend yield 41.91
Payout ratio 448.32%
Dividend date 322 Apr 2024
Ex-dividend date 405 Apr 2024
Last split factor 22:1
Last split date 321 June 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.11%
Operating margin (ttm)13.40%

Management effectiveness

Return on assets (ttm)6.20%
Return on equity (ttm)14.15%

Income statement

Revenue (ttm)9.29B
Revenue per share (ttm)83.11
Quarterly revenue growth (yoy)1.50%
Gross profit (ttm)N/A
EBITDA 1.78B
Net income avi to common (ttm)842M
Diluted EPS (ttm)7.43
Quarterly earnings growth (yoy)-4.00%

Balance sheet

Total cash (mrq)474M
Total cash per share (mrq)4.27
Total debt (mrq)5.35B
Total debt/equity (mrq)81.76%
Current ratio (mrq)0.97
Book value per share (mrq)57.95

Cash flow statement

Operating cash flow (ttm)1.33B
Levered free cash flow (ttm)784M